Static export generated 2026-07-28 07:45Z from the private Meridian research build — every value keeps its own as-of timestamp and provenance label; search, filters and admin actions are inactive in this copy. Private academic review only — not for redistribution.
MERIDIAN Regulatory & Corporate Impact Intelligence — personal research build
Data coverage is not complete: 3 source(s) failing; 24 open coverage incident(s); 1 source(s) awaiting credentials; 3 source(s) unverified. Details on the Source Health page — gaps are shown, never concealed.

Knowledge graph — Basler Kantonalbank

← Graph overview · Company profile

Ego network — drawn from persisted matches only

Central node: company. Connected nodes: matched regulatory instruments / sanctions-list entries (each links to its record). Edge label: rule key; edge thickness: applicability; edge opacity: confidence (Calculated Metrics, formula impact-1.1). Every edge is a review-gated candidate backed by stored evidence — nothing inferred is drawn.

Ego network for Basler Kantonalbank: 24 rule-generated match edge(s) to 17 connected node(s). The table after this graphic lists the identical edges.R-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - FINMA publishes supplementary guidance on money laundering risk analysis; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - FINMA publishes new ordinance on risk diversification for banks and securities firms; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - FINMA publishes guidance on managing digital fraud risks; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - FINMA proceedings: MBaer Merchant Bank AG in liquidation; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - Measures at MBaer Merchant Bank AG; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - Alain Girard to assume leadership of FINMA’s Banks division; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - Ex-post evaluation of Circular 2019/2 “Interest rate risks – banks”; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-FINMA-BANKR-FINMA-BANK: Basler Kantonalbank - FINMA publishes a new ordinance on the liquidity of banks and securities firms; applicability 0.94, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Insurance intermediaries: supervision is having an impact, but there is still a need for action to tackle abuse; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-BANKING_SUPERVISIONR-SECTOR-BANKING_SUPERVISION: Basler Kantonalbank - FINMA publishes supplementary guidance on money laundering risk analysis; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-BANKING_SUPERVISIONR-SECTOR-BANKING_SUPERVISION: Basler Kantonalbank - FINMA publishes new ordinance on risk diversification for banks and securities firms; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-BANKING_SUPERVISIONR-SECTOR-BANKING_SUPERVISION: Basler Kantonalbank - FINMA publishes guidance on managing digital fraud risks; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-BANKING_SUPERVISIONR-SECTOR-BANKING_SUPERVISION: Basler Kantonalbank - FINMA proceedings: MBaer Merchant Bank AG in liquidation; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-BANKING_SUPERVISIONR-SECTOR-BANKING_SUPERVISION: Basler Kantonalbank - Measures at MBaer Merchant Bank AG; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-BANKING_SUPERVISIONR-SECTOR-BANKING_SUPERVISION: Basler Kantonalbank - Alain Girard to assume leadership of FINMA’s Banks division; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Hedwig Ulmer Busenhart joins FINMA’s Executive Board; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-MARKET_CONDUCTR-SECTOR-MARKET_CONDUCT: Basler Kantonalbank - Swiss Takeover Board: Beat Fellmann’s term of office extended by one year; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-BANKING_SUPERVISIONR-SECTOR-BANKING_SUPERVISION: Basler Kantonalbank - Ex-post evaluation of Circular 2019/2 “Interest rate risks – banks”; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Insurance intermediary certificates unlawfully obtained due to manipulation; applicability 0.65, confidence 0.78, 2 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation; applicability 0.65, confidence 0.68, 3 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis; applicability 0.65, confidence 0.68, 3 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorber; applicability 0.65, confidence 0.68, 3 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep System; applicability 0.65, confidence 0.68, 3 evidence item(s); review status needs_reviewR-SECTOR-INSURANCE_SUPERVISIONR-SECTOR-INSURANCE_SUPERVISION: Basler Kantonalbank - Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs Syndrome; applicability 0.65, confidence 0.68, 3 evidence item(s); review status needs_reviewFINMA publishes supplem…FINMA publishes supplementary guidance on money laundering risk analysis (sanction_measure) - open instrument recordFINMA publishes new ord…FINMA publishes new ordinance on risk diversification for banks and securities firms (sanction_measure) - open instrument recordFINMA publishes guidanc…FINMA publishes guidance on managing digital fraud risks (sanction_measure) - open instrument recordFINMA proceedings: MBae…FINMA proceedings: MBaer Merchant Bank AG in liquidation (sanction_measure) - open instrument recordMeasures at MBaer Merch…Measures at MBaer Merchant Bank AG (sanction_measure) - open instrument recordAlain Girard to assume …Alain Girard to assume leadership of FINMA’s Banks division (sanction_measure) - open instrument recordEx-post evaluation of C…Ex-post evaluation of Circular 2019/2 “Interest rate risks – banks” (sanction_measure) - open instrument recordFINMA publishes a new o…FINMA publishes a new ordinance on the liquidity of banks and securities firms (sanction_measure) - open instrument recordInsurance intermediarie…Insurance intermediaries: supervision is having an impact, but there is still a need for action to tackle abuse (sanction_measure) - open instrument recordHedwig Ulmer Busenhart …Hedwig Ulmer Busenhart joins FINMA’s Executive Board (sanction_measure) - open instrument recordSwiss Takeover Board: B…Swiss Takeover Board: Beat Fellmann’s term of office extended by one year (sanction_measure) - open instrument recordInsurance intermediary …Insurance intermediary certificates unlawfully obtained due to manipulation (sanction_measure) - open instrument recordMedical Devices; Anesth…Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation (rule) - open instrument recordMedical Devices; Genera…Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis (rule) - open instrument recordMedical Devices; Orthop…Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorber (rule) - open instrument recordMedical Devices; Genera…Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep System (rule) - open instrument recordMedical Devices; Neurol…Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs Syndrome (rule) - open instrument recordBasler KantonalbankBasler Kantonalbank - open company profile

+19 more match(es) exist for this company but are not drawn: the graph caps at 25 nodes rather than cluttering or sampling silently. The complete list is on the company profile.

The same edges as an accessible table

Screen-reader parity: this table lists exactly the edges drawn above, in the same order.

Rule (match)Connected nodeNode typeRelationshipApplicabilityConfidenceEvidenceReview
R-FINMA-BANKFINMA publishes supplementary guidance on money laundering risk analysissanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-FINMA-BANKFINMA publishes new ordinance on risk diversification for banks and securities firmssanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-FINMA-BANKFINMA publishes guidance on managing digital fraud riskssanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-FINMA-BANKFINMA proceedings: MBaer Merchant Bank AG in liquidationsanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-FINMA-BANKMeasures at MBaer Merchant Bank AGsanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-FINMA-BANKAlain Girard to assume leadership of FINMA’s Banks divisionsanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-FINMA-BANKEx-post evaluation of Circular 2019/2 “Interest rate risks – banks”sanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-FINMA-BANKFINMA publishes a new ordinance on the liquidity of banks and securities firmssanction_measureprudential_supervision_applicability0.940.782 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONInsurance intermediaries: supervision is having an impact, but there is still a need for action to …sanction_measuresector_topic_candidate_insurance_supervision0.650.782 item(s)needs_review
R-SECTOR-BANKING_SUPERVISIONFINMA publishes supplementary guidance on money laundering risk analysissanction_measuresector_topic_candidate_banking_supervision0.650.782 item(s)needs_review
R-SECTOR-BANKING_SUPERVISIONFINMA publishes new ordinance on risk diversification for banks and securities firmssanction_measuresector_topic_candidate_banking_supervision0.650.782 item(s)needs_review
R-SECTOR-BANKING_SUPERVISIONFINMA publishes guidance on managing digital fraud riskssanction_measuresector_topic_candidate_banking_supervision0.650.782 item(s)needs_review
R-SECTOR-BANKING_SUPERVISIONFINMA proceedings: MBaer Merchant Bank AG in liquidationsanction_measuresector_topic_candidate_banking_supervision0.650.782 item(s)needs_review
R-SECTOR-BANKING_SUPERVISIONMeasures at MBaer Merchant Bank AGsanction_measuresector_topic_candidate_banking_supervision0.650.782 item(s)needs_review
R-SECTOR-BANKING_SUPERVISIONAlain Girard to assume leadership of FINMA’s Banks divisionsanction_measuresector_topic_candidate_banking_supervision0.650.782 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONHedwig Ulmer Busenhart joins FINMA’s Executive Boardsanction_measuresector_topic_candidate_insurance_supervision0.650.782 item(s)needs_review
R-SECTOR-MARKET_CONDUCTSwiss Takeover Board: Beat Fellmann’s term of office extended by one yearsanction_measuresector_topic_candidate_market_conduct0.650.782 item(s)needs_review
R-SECTOR-BANKING_SUPERVISIONEx-post evaluation of Circular 2019/2 “Interest rate risks – banks”sanction_measuresector_topic_candidate_banking_supervision0.650.782 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONInsurance intermediary certificates unlawfully obtained due to manipulationsanction_measuresector_topic_candidate_insurance_supervision0.650.782 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONMedical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairmen…rulesector_topic_candidate_insurance_supervision0.650.683 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONMedical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatmen…rulesector_topic_candidate_insurance_supervision0.650.683 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONMedical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorberrulesector_topic_candidate_insurance_supervision0.650.683 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONMedical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sle…rulesector_topic_candidate_insurance_supervision0.650.683 item(s)needs_review
R-SECTOR-INSURANCE_SUPERVISIONMedical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimula…rulesector_topic_candidate_insurance_supervision0.650.683 item(s)needs_review